Pap Smear Testing

Human-papillomavirus (HPV) DNA testing has been proposed as an alternative to primary cervical cancer screening using cytological testing. Review of the evidence shows that available data are conflicting for

What is the Human Papillomavirus? Commonly known as HPV, it is an infection that spreads through sexual contact. There are over one hundred different types of HPV; several types cause genital warts, while other high risk strands can lead to cancer of the cervix, anus, vagina, and penis. Because HPV is often asymptomatic, many people are unaware of their infection status, and thus, their potential for transmitting the virus to a sexual partner. The significance of the Human Papillomavirus is that fifty percent of Americans who are sexually active will contract it within their lives, and at any given point there are twenty million Americans already infected with it (“By the numbers: HPV Vaccine”).

Getting a cervical cancer screening with a Pap Smear can enable a practitioner to detect early signs of cervical cancer by allowing identification of precancerous lesions (USPSTF, 2016a). Early detection can decrease the incidence of cervical cancer and, ultimately, reduce mortality rates related to cervical cancer (USPSTF, 2016a).

If the Pap smear test results reveal abnormal cell changes, a physician will recommend for a women to undergo a colposcopy. A colposcopy is a procedure where a physician washes the cervix with a diluted vinegar solution and uses a microscope-like tool known as a colposcope to have a magnified view of the surface of the vagina and cervix. If the physician sees any abnormal areas, such as lesions on the cervix, then tissue samples are taken for examination under a microscope. Other than the Pap smear, a pelvic exam may be performed. In a pelvic exam, the vagina, along with adjacent organs, is examined visually and manually. A speculum, and instrument that separates tissue, is inserted into the vagina for visual examination. After, the organs are felt with the fingers by inserting one hand in the vagina, and putting the other hand on the abdomen to feel for any abnormalities. If invasive cervical cancer is suspected, or if the colposcopy and the Pap smear have different results, then other tests may be conducted. One test that may be performed is a cone biopsy. In a cone biopsy, a larger, cone shaped sample of cervical tissue is taken and examined for cancer cells. Another test that may be performed is endocervical curettage. During this procedure, the lining of the cervix is scraped and examined for cancer cells. Once a diagnosis of cervical cancer is made, then the

However even though there are many problem with the Pap smear, the most important error is failure of women to get a Pap smear (Dziura, 2009). As it is harder to monitor any changes in the cervical cancer if you don’t turn up for regular

Early detection of breast and cervical cancer reduced the burden of disease in women. The practices of Screening shown reduce the level of mortality and improve quality of life. The Every Woman Matters (EWM)stared in 1992 it is a federally-funded program designed to remove barrier to early screening by providing awareness and make screening more financially accessible to woman who have limited or no health insurance. The eligible women receive pay for office visits with associated clinical breast examination, pelvic examination, Papanicolaou smear test, and lab fees (Backer et al., 2004). Age-appropriate mammography and limited number of diagnostic test is also covered under program. In this paper I will

Early detection of breast and cervical cancer reduced the burden of disease in women. The practices of Screening shown reduce the level of mortality and improve quality of life. The Every Woman Matters (EWM)stared in 1992 it is a federally-funded program designed to remove barrier to early screening by providing awareness and make screening more financially accessible to woman who have limited or no health insurance. The eligible women receive pay for office visits with associated clinical breast examination, pelvic examination, Papanicolaou smear test, and lab fees (Backer et al., 2004). Age-appropriate mammography and limited number of diagnostic test is also covered under program. In this paper I will

A pap test is better known as a “pap smear” and it checks for cervical cancer. During a pap smear the physician collects a sample of cells from a woman’s cervix. Then the cells are placed on a microscope and examined for abnormalities that could be an indication of cervical cancer. A breast exam is done by a physician when a physician feels a person’s breast and underarm area to search for any abnormalities that could be an indication of breast cancer. Early detection of either cancer provides a higher survival rate. Planned Parenthood works with women with and without insurance to ensure they get the testing and care they

Prophylactic vaccination against high risk human papilloma virus 16 and 18 represents an exciting means of protection against HPV related malignancy. However, this strategy alone, even if there is a level of cross protection against other oncogenic viruses, cannot completely prevent cervical cancer. In some countries cervical screening programs have reduced the incidence of invasive cervical cancer by up to 80 percent although this decline has now reached a plateau with current cancers occurring in patients who have failed to attend for screening or where the sensitivity of the tests have proved inadequate. Cervical screening is inevitably associated with significant anxiety for the many women who require investigation and treatment following abnormal cervical cytology. However, it is vitally important to stress the need for continued cervical screening to complement vaccination in order to optimize prevention in vaccines and prevent cervical cancer in older women where the value of vaccination is currently unclear. It is likely that vaccination will ultimately change the natural history of HPV disease by reducing the influence of the highly oncogenic types HPV 16 and 18. In the long term this is likely to lead to an increase in recommended screening intervals. HPV vaccination may also reduce

The paper Prostate Cancer Screening is written as an analysis of the controversy on the use of screening for prostate cancer. The paper itself is written between doctors Elie Mulhem, Nikolaus Fulbright, and Norah Duncan. The analysis, while likely directed to those in the medical field, is tailored to be easily understood by laypeople. While the paper itself is a somewhat brief, surface level analysis of the situation, it does support the notion that prostate cancer screening through methods like prostate-specific antigen (PSA) testing and digital-rectal examinations (DRE) have questionable effectiveness. The intention of the paper appears to persuade doctors and the public to the viewpoint that prostate

Cervical cancer is one of the highly popular disease for the women. Different programmes has been made up to fight against this deadly disease. New Zealand has one of the best screening programmes in the world. The establishment of National Cervical Cancer Screening Programme in NZ in 1990 had reduced a significant number of 60% of women who develop cervical cancer and who die from it since it was built. More than 1 million New Zealander women are enrolled in this programme and 95 % are eligible. The Cervical Cancer screening programme aims to; informing women about the importance of having the cervical screening tests; promoting cervical screening tests on a regular basis to women aged 20–70; ensuring high-quality and culturally appropriate services; supporting women with abnormal tests; ensuring there is regular monitoring to see that the goals of the programme are being met. The NCSP also acknowledges the importance of the Treaty of Waitangi in providing a screening programme that is successful for all New Zealand women.

Among the many arguments for mandatory HPV vaccination, the foremost is that it is an important medical achievement and a major public health milestone. This vaccine has proven to be one-hundred percent effective in preventing the 4 HPV strains that are responsible for seventy percent of cervical cancers and ninety percent of genital warts. In addition, no serious side effects have been identified. Because this vaccine is a preventive measure, administration before onset of sexual activity is ideal; however, even females who have been sexually active can still benefit from this vaccination (Perkins et al., 2010). Nationally and internationally, the HPV vaccine will significantly reduce disease burden by reducing monetary and psychological costs of invasive procedures that remove precancerous and cancerous lesions. By combining vaccination with routine Pap smear screening, these public health efforts have the remarkable opportunity to eradicate cervical cancer (Ramet et al., 2011).

Despite these difficulties, researchers have reported the benefits of health screening. The most recognised benefit according to Durojaiye (2009) is that it is effective in reducing morbidity and mortality from disease by detecting it before symptoms occur. A report in 2006 by the Advisory Committee on Breast Cancer Screening showed that screening saves 1,400 lives a year in England. In Australia, the age-standardized breast cancer mortality rate in women of all ages declined significantly from 28 per 100,000 women in 1996 to 24 per 100,000 in 2005. Mortality from breast cancer among women aged 50-69 was reported to have declined from 62 deaths per 100,000 in 1996 to 52 deaths per 100,000 in 2005 (Australian Institute of Health and Welfare, 2008) . The screening of pregnant women to identify and intervene early with risks to their health and that of their babies are associated with improved health status among high-risk populations (Durojaiye, 2009). The idea of screening therefore is to prevent, not to cure. Wardle & Pope (1992) state that screening is the second best prevention option, but one which provides the best chance of saving lives in our present state of knowledge. It may also provide welcome reassurance especially to many women that they do not have cancer. If the screening consultations are used wisely, an

Despite the difficulty, researchers have reported the benefits of screening. The most recognized benefit of health screening according to Durojaiye, (2009) is it’s effectiveness in reducing morbidity and mortality from disease by detecting it before symptoms occur. A report in 2006, by the Advisory Committee on Breast Cancer Screening, shows that screening saves 1,400 lives a year in England. In Australia, The age-standardized breast cancer mortality rate in women of all ages declined significantly from 28 per 100,000 women in 1996 to 24 per 100,000 in 2005. Mortality from breast cancer among women aged 50-69 was reported to have declined from 62 deaths per 100,000 in 1996 to 52 deaths per 100,000 in 2005 (Australian Institute of Health and Welfare, 2008) . Evidence also suggests that a reduction in death rates of around 95% is possible in the long-term with cervical cancer screening. The screening of pregnant women to identify and intervene early with risks to their health and that of their babies are associated with improved health status among high-risk populations (Durojaiye, 2009). The idea of screening therefore is to prevent, not to cure. Pope (1992), stats that screening is the second best option, but one which

Cervical cancer is one of the leading causes of cancer related mortality in countries such as India accounting for more than 17% of all cancer deaths in women aged 30-69. [3] Cervical cancer is one such type of cancer in which screening plays a significant role. Clinical trials done in below poverty level populations do encounter ethical issues to a certain extent with regards to informed consent as most or all of these patients are illiterate. However informed consent is extremely important when justifying data for such clinical trials. Countries such as US have implemented Pap smear screening as one of the most important cervical cancer screening methods. In countries as densely populated as India where proper healthcare facilities does not reach slums and extremely poverty stricken societies, alternatives for screening are indicated- VIA or Visual inspection with acetic acid